Your search returned 5 results.

Sort
Results
1.
High screen failure rate in patients with resistant hypertension: Findings from SYMPLICITY HTN-3. MedStar authors:
  • Garcia-Garcia, Hector M
  • Steinvil, Arie
  • Waksman, Ron
PMID:
  • 28938966
Year: 2017
Citation:
  • American Heart Journal. 192:76-84, 2017 Oct
Institution:
  • MedStar Heart & Vascular Institute
Medline publication type:
  • Journal Article
  • Multicenter Study
  • Randomized Controlled Trial
Form of publication:
  • Journal Article
All authors:
  • Bakris GL, Bhatt DL, Brown AL, DeBruin V, DiFilippo W, Garcia-Garcia H, Jolivette D, Jones D, Scott T, Singh J, Steinvil A, Waksman R
2.
An Evolving Role for Cancer Rehabilitation in the Era of Low-Dose Lung Computed Tomography Screening. [Review] MedStar authors:
  • Khanna, Ashish
  • Wisotzky, Eric M
PMID:
  • 28942912
Year: 2017
Citation:
  • Pm & R. 9(9S2):S407-S414, 2017 Sep
Institution:
  • MedStar National Rehabilitation Network
Medline publication type:
  • Journal Article
  • Review
Form of publication:
  • Journal Article
All authors:
  • Khanna A, Smith SR, Wisotzky EM
3.
Evolution and impact of lymph node dissection during pancreaticoduodenectomy for pancreatic cancer. MedStar authors:
  • Al-Refaie, Waddah B
PMID:
  • 27865602
Year: 2017
Citation:
  • Surgery. 161(4):968-976, 2017 Apr
Institution:
  • MedStar Health Research Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Al-Refaie W, Ayata G, de Geus SW, Eskander MF, Kasumova GG, Ng SC, Tseng JF
4.
Correlation of Long-term Results of Imatinib in Advanced Gastrointestinal Stromal Tumors With Next-Generation Sequencing Results: Analysis of Phase 3 SWOG Intergroup Trial S0033. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 28196207
Year: 2017
Citation:
  • JAMA Oncology. , 2017 Feb 09
  • JAMA Oncology. 3(7):944-952, 2017 Jul 01
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Baker LH, Benjamin RS, Blackstein ME, Blanke CD, Borden EC, Corless CL, Crowley JJ, Demetri GD, Fletcher JA, Heinrich M, Maki RG, Owzar K, Priebat DA, Rankin C, Ryan CW, Tap WD, von Mehren M
5.
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial. MedStar authors:
  • Priebat, Dennis A
PMID:
  • 28988646
Year: 2017
Citation:
  • Lancet Oncology. 18(11):1493-1501, 2017 Nov
Institution:
  • Washington Cancer Institute
Medline publication type:
  • Journal Article
Form of publication:
  • Journal Article
All authors:
  • Attia S, Baker LH, Bolejack V, Burgess M, Butterfield LH, Crowley J, D'Angelo S, Davis LE, Hu J, Lazar AJ, Maki RG, Movva S, Okuno SH, Patel S, Priebat DA, Reed DR, Reinke D, Riedel RF, Rodriguez-Canales J, Salazar R, Schuetze SM, Tawbi HA, Van Tine BA, Wistuba II
Pages

Powered by Koha